000 01389 a2200421 4500
005 20250517172334.0
264 0 _c20181030
008 201810s 0 0 eng d
022 _a2589-0646
024 7 _a10.1016/j.hemonc.2017.07.001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aShebl, Shebl Said
245 0 0 _aThrombo-hemorrhagic liability in children with congenital heart diseases.
_h[electronic resource]
260 _bHematology/oncology and stem cell therapy
_cSep 2018
300 _a123-128 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aBleeding Time
650 0 4 _aBlood Coagulation Tests
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aE-Selectin
_xblood
650 0 4 _aFemale
650 0 4 _aHeart Defects, Congenital
_xblood
650 0 4 _aHemorrhage
_xblood
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aMale
650 0 4 _aP-Selectin
_xblood
650 0 4 _aPlatelet Count
650 0 4 _aThrombosis
_xblood
700 1 _aEl-Shehaby, Walid Ahmed Naguib
700 1 _aSaid, Yasmin Shebl
700 1 _aDarwish, Amira Hamed
700 1 _aElfadaly, Nabeh Helal
700 1 _aAmer, Eman
773 0 _tHematology/oncology and stem cell therapy
_gvol. 11
_gno. 3
_gp. 123-128
856 4 0 _uhttps://doi.org/10.1016/j.hemonc.2017.07.001
_zAvailable from publisher's website
999 _c27523348
_d27523348